Biohit Oyj signed a licensing agreement with Grand Pharmaceutical (China) Company Limited. The agreement gives GrandPharma the rights to use intellectual property rights and know-how of the company to exclusively manufacture market and distribute in China the acetaldehyde binding products developed by the company.